<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/2004/02/skos/core#altLabel>	"Safety and effectiveness of istradefylline in patients with Parkinson\u2019s disease: interim analysis of a post-marketing surveillance study in Japan"@en .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P2093>	"Mayumi Saki" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P433>	"15" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct-normalized/P698>	<http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30281377> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P921>	<http://www.wikidata.org/entity/Q11085> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct-normalized/P356>	<http://dx.doi.org/10.1080/14656566.2018.1518433> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P356>	"10.1080/14656566.2018.1518433" .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/name>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@nl .
<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@nl .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P921>	<http://www.wikidata.org/entity/statement/Q57036364-07170F7D-EF23-4165-8F99-9FD91FD35A51> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P921>	<http://www.wikidata.org/entity/statement/Q57036364-0D59952C-ADAF-4FF8-9504-76C79F19136E> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P2093>	"Makio Takahashi" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q57036364-463E1A19-4A15-4632-9FC6-944B598258C1> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P2093>	"Naoko Asai" .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/name>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@en .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P356>	<http://www.wikidata.org/entity/statement/Q57036364-EBB1D5DA-15BE-4E73-B2E0-661D3D5B008A> .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/description>	"article scientifique publi\u00E9 en 2018"@fr .
<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@en .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q57036364-7191213F-F87D-4B34-9157-B83D73B0AF25> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q57036364-83D3D273-896A-4ECA-9D95-5C4FD8C91486> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P2093>	"Masaki Fujita" .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/description>	"wetenschappelijk artikel"@nl .
<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P4011>	<http://www.wikidata.org/entity/statement/Q57036364-6ADBA77C-4ABD-4237-9D46-3895C824C1DD> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P407>	<http://www.wikidata.org/entity/statement/Q57036364-87E6D70D-F5DE-4D5A-B9DC-A62A295BA794> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q57036364-3D115730-C62F-462D-8FA7-5D3143A628E5> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P478>	"19" .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/description>	"\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0436\u043E\u0432\u0442\u043D\u0456 2018"@uk .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P577>	"2018-10-03T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P304>	<http://www.wikidata.org/entity/statement/Q57036364-0EC6433C-9BD9-4812-A935-8023CDB82D5F> .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/description>	"im Oktober 2018 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P1433>	<http://www.wikidata.org/entity/Q5421212> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q57036364-4251511E-F679-4FED-B219-B6C8D378ACFA> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P2093>	"Akihisa Mori" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P698>	"30281377" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q57036364-BB50CA3A-C869-4931-8F3A-3579802DDBF1> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P577>	<http://www.wikidata.org/entity/statement/Q57036364-97A7830F-EB9F-49EC-BF04-D12F71006916> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q13442814> .
<http://www.wikidata.org/entity/Q57036364>	<http://schema.org/description>	"scholarly article by Makio Takahashi et al published 3 October 2018 in Expert Opinion on Pharmacotherapy"@en .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q57036364-8BF61DBA-C2B1-4508-ABA0-29061A837198> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P921>	<http://www.wikidata.org/entity/Q17> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P698>	<http://www.wikidata.org/entity/statement/Q57036364-5E29B19F-8656-4C12-924C-789CB1FE00DD> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/2000/01/rdf-schema#label>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@nl .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P1433>	<http://www.wikidata.org/entity/statement/Q57036364-926D4CCB-9FB6-49A4-B82F-13F1368F8F27> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P478>	<http://www.wikidata.org/entity/statement/Q57036364-BA07DCD1-56D7-4A67-A6DD-DE7FF99F67EA> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/P433>	<http://www.wikidata.org/entity/statement/Q57036364-FD914DAB-04ED-4826-B326-00D9E1B6011C> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P4011>	"fc4459b3b11c857cbfae4910e23575fa34481343" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P407>	<http://www.wikidata.org/entity/Q1860> .
<http://www.wikidata.org/entity/Q57036364>	<http://www.w3.org/2000/01/rdf-schema#label>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@en .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P304>	"1-8" .
<http://www.wikidata.org/entity/Q57036364>	<http://www.wikidata.org/prop/direct/P1476>	"Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan"@en .